These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734 [TBL] [Abstract][Full Text] [Related]
29. An open-label, add-on study of pregabalin in patients with partial seizures: a multicenter trial in Greece. Tsounis S; Kimiskidis VK; Kazis D; Gkiatas K; Garganis K; Karageorgiou K; Giannakodimos S; Papathanasopoulos P; Plaitakis A; Papadimitriou A; Lyras L; Emir B Seizure; 2011 Nov; 20(9):701-5. PubMed ID: 21775167 [TBL] [Abstract][Full Text] [Related]
30. Defining success in clinical trials--profiling pregabalin, the newest AED. Ryvlin P Eur J Neurol; 2005 Nov; 12 Suppl 4():12-21. PubMed ID: 16144536 [TBL] [Abstract][Full Text] [Related]
31. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. Arnold LM; Russell IJ; Diri EW; Duan WR; Young JP; Sharma U; Martin SA; Barrett JA; Haig G J Pain; 2008 Sep; 9(9):792-805. PubMed ID: 18524684 [TBL] [Abstract][Full Text] [Related]
32. Pregabalin in neuropathic pain: a more "pharmaceutically elegant" gabapentin? Guay DR Am J Geriatr Pharmacother; 2005 Dec; 3(4):274-87. PubMed ID: 16503325 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China. Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113 [TBL] [Abstract][Full Text] [Related]
34. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Crofford LJ; Rowbotham MC; Mease PJ; Russell IJ; Dworkin RH; Corbin AE; Young JP; LaMoreaux LK; Martin SA; Sharma U; Arthritis Rheum; 2005 Apr; 52(4):1264-73. PubMed ID: 15818684 [TBL] [Abstract][Full Text] [Related]
35. Pregabalin pharmacology and its relevance to clinical practice. Ben-Menachem E Epilepsia; 2004; 45 Suppl 6():13-8. PubMed ID: 15315511 [TBL] [Abstract][Full Text] [Related]
36. Erectile dysfunction associated with pregabalin add-on treatment in patients with partial seizures: five case reports. Hitiris N; Barrett JA; Brodie MJ Epilepsy Behav; 2006 Mar; 8(2):418-21. PubMed ID: 16446121 [TBL] [Abstract][Full Text] [Related]
37. Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin. Huppertz HJ; Feuerstein TJ; Schulze-Bonhage A Epilepsia; 2001 Jun; 42(6):790-2. PubMed ID: 11422338 [TBL] [Abstract][Full Text] [Related]
38. A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome. Allen R; Chen C; Soaita A; Wohlberg C; Knapp L; Peterson BT; García-Borreguero D; Miceli J Sleep Med; 2010 Jun; 11(6):512-9. PubMed ID: 20466589 [TBL] [Abstract][Full Text] [Related]
39. Pregabalin: a new neuromodulator with broad therapeutic indications. Shneker BF; McAuley JW Ann Pharmacother; 2005 Dec; 39(12):2029-37. PubMed ID: 16288079 [TBL] [Abstract][Full Text] [Related]
40. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures. Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]